RecruitingNCT06038409
Ketamine Treatment Plans for Chronic Conditions
Understanding the Safety of Home Ketamine Treatment Plans for Chronic Conditions
Sponsor
RIVER Foundation
Enrollment
500 participants
Start Date
Jan 1, 2023
Study Type
OBSERVATIONAL
Conditions
Summary
A study aimed to assess the efficacy of the various approaches to prescribing Ketamine currently in use off-label. The focus will be to include ketamine within the study plan of those with chronic conditions who are receiving ketamine.
Eligibility
Min Age: 18 Years
Inclusion Criteria1
- Must have an identifiable chronic condition.
Exclusion Criteria1
- Healthy population
Interventions
DRUGKetamine
The efficacy of the various approaches to prescribing Ketamine currently in use off-label. The focus will be to include ketamine within the treatment plan of those with chronic conditions
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06038409
Related Trials
Study of Neuro-Cognitive Correlates of Pediatric Anxiety Disorders
NCT000180571 location
Development of Magnetic Resonance Imaging Techniques for Studying Mood and Anxiety Disorders
NCT003971111 location
Modulating Anxious Coping
NCT048241051 location
Healthy Behaviors for Insomnia Prevention in People With HIV and Ongoing Pain
NCT072704061 location
Intervention Effect of Temporal Interference Stimulation (TIS) on Depressive Disorder
NCT071913922 locations